Építés alatt – nem éles oldal
Belépés

What researchers published on Diffúz nagy B-sejtes limfóma (DLBCL)

13 680 papers, newest first.

Showing 40 of 13 680

  • ÁttekintésImmunotherapies and Chemo-Sparing Approaches: A New Era for Diffuse Large B-Cell Lymphoma in Older Patients.Cancers
  • Prognostic analysis of HALP -LDH composite model in newly diagnosed diffuse large B-cell lymphoma patients.Frontiers in physiology
  • Real-world access and barriers to CAR T-cell therapy in relapsed/refractory diffuse large B-cell lymphoma: a population-based study.Transplantation and cellular therapy
  • Spatial topology on baseline PET/CT improves risk stratification in disseminated diffuse large B-cell lymphoma: a multicenter study.Cancer imaging : the official publication of the International Cancer Imaging Society
  • EsetismertetésSuccessful salvage therapy with glofitamab followed by selinexor maintenance in an elderly patient with primary refractory diffuse large b-cell lymphoma harboring TP53 and CD58 mutations: a case report and literature review.Frontiers in oncology
  • LILRB1 as a novel therapeutic target for CAR-T therapy in diffuse large B cell lymphoma.Molecular therapy : the journal of the American Society of Gene Therapy
  • Targeting CCR7 Attenuates Aggressive Phenotypes in Diffuse Large B-Cell Lymphoma by Suppressing Wnt/β-Catenin Signaling.Cancer medicine
  • Discovery of Tricyclic Oxazinoquinolinone-Based BCL6 PROTAC Degraders with Potent Activity Against Diffuse Large B-Cell Lymphoma.Journal of medicinal chemistry
  • Physiologic and pharmacologic role of the glucocorticoid receptor in germinal center B cells and plasmacytic differentiation.Proceedings of the National Academy of Sciences of the United States of America
  • Clinical characteristics and prognosis analysis of secondary intestinal diffuse large B-cell lymphoma: a multi-center retrospective study over a decade.Frontiers in oncology
  • Integrative transcriptomic and in silico analysis identifies novel long non-coding RNAs associated with BCL6 and SPARC in diffuse large B-cell lymphoma.Computational biology and chemistry
  • [Mitoxantrone hydrochloride liposomes combined with R-GDP regimen in the treatment of relapsed/refractory diffuse large B-cell lymphoma: a single-arm, multicenter, exploratory clinical study].Zhonghua zhong liu za zhi [Chinese journal of oncology]
  • Orbital Diffuse Large B-Cell Lymphoma Masquerading as Periorbital Cellulitis in a Paediatric Patient With Ataxia-Telangiectasia: A Case Report.Case reports in oncological medicine
  • Multiple and central nervous system extranodal involvement predict poor prognosis in R/R DLBCL following CD19 CAR-T therapy.Leukemia research
  • EsetismertetésIntravascular large B-cell lymphoma presenting as unilateral lymphedema in a patient with rheumatoid arthritis and sarcoidosis: A case report.Medicine
  • Orelabrutinib plus R-CHOP in patients with newly diagnosed non-GCB double-expressor DLBCL: A single-arm, phase II study.British journal of haematology
  • An immunogenic cell death related signature links efferocytosis to immunosuppression and therapeutic vulnerabilities in DLBCL.BMC immunology
  • EsetismertetésDiffuse Large B-Cell Lymphoma Presenting as Clinically Isolated Massive Splenic Disease: A Case Report.Cureus
  • Dynamic prognostic stratification and survival prediction in elderly patients with diffuse large B-cell lymphoma: a real-world evidence study.BMC cancer
  • EsetismertetésIntermittent reduced-dose methotrexate enabled continuation of induction therapy despite severe delayed methotrexate elimination in primary central nervous system lymphoma: a case report.Journal of medical case reports
  • Áttekintés[Treatment strategies for lymphoma in older adults].[Rinsho ketsueki] The Japanese journal of clinical hematology
  • Patient-reported Outcomes in Patients With Relapsed or Refractory Diffuse Large B-cell Lymphoma Treated With Glofitamab Plus Gemcitabine and Oxaliplatin in STARGLO.Clinical lymphoma, myeloma & leukemia
  • Temporal clinical trajectories and Day+14 landmark stratification of infection risk after CD19 CAR T-cell therapy.Frontiers in cellular and infection microbiology
  • Diffuse Large B-Cell Lymphoma Presenting as a Rapidly Enlarging Forehead Mass Initially Suggestive of a Subgaleal Hematoma: A Case Report.Clinical case reports
  • EsetismertetésDiffuse Large B-cell Lymphoma With Tumor Thrombus in the Superior Mesenteric Vein: A Case Report.Cureus
  • Hypoxia-induced NETs establish a self-reinforcing immunosuppressive circuit that can be targeted to enhance immunotherapy in DLBCL.Journal of translational medicine
  • Correction: Deceptive initial presentation of systemic DLBCL with CNS progression following oligometabolic PET/CT: case report.Frontiers in oncology
  • EsetismertetésPrimary Cervical Diffuse Large B-cell Lymphoma Incidentally Diagnosed During Evaluation of High-Grade Cervical Dysplasia: A Case Report.Cureus
  • Projected population size by treatment line in diffuse large B-cell lymphoma in the United States, 2024-2028.Leukemia & lymphoma
  • Expression profiles of long non-coding RNAs ROCR, CFLAR-AS1, ST7-AS1, and ST7-AS2 in diffuse large B-cell lymphoma: a case-control study focusing on GCB and non-GCB subtypes.BMC medical genomics
  • Correction: Zanubrutinib combined with R-CHOP in previously untreated diffuse large B-cell lymphoma with specific gene alteration: a phase II study.Blood cancer journal
  • Esetismertetés[Cardiac Malignant Lymphoma with Right Atrial Occlusion Responding to Tumor Resection and Postoperative Chemotherapy:Report of a Case].Kyobu geka. The Japanese journal of thoracic surgery
  • Efficacy and safety of orelabrutinib plus R-CDOP as first-line therapy in diffuse large B-cell lymphoma with high-risk CNS-IPI: a prospective, multicenter, single-arm, phase II study.Frontiers in oncology
  • EsetismertetésLower Back Pain As the Initial Manifestation of Primary Follicular B-cell Non-Hodgkin Lymphoma of the Bone Marrow: A Case Report.Cureus
  • Generation and multidimensional profiling of a rituximab-resistant ABC-type diffuse large B-cell lymphoma cell line.Epigenomics
  • The cyclin-G associated kinase (GAK) is a clinically actionable drug target required for mitosis in diffuse large B-cell lymphoma.Leukemia
  • ÁttekintésProgression-free survival prediction in diffuse large B-cell lymphoma: where can we further improve?Expert review of hematology
  • Baseline Spleen Volume is Independently Associated With Survival After CD19-Directed Chimeric Antigen Receptor T-Cell Therapy in Relapsed/Refractory Diffuse Large B-Cell Lymphoma.Hematological oncology
  • EsetismertetésEpcoritamab achieves durable remission after CD20 antigen escape in primary cardiac diffuse large B-cell lymphoma.Annals of hematology
  • Áttekintés[Reappraisal of the value of CD30 testing in the diagnosis and treatment of lymphoma].Zhonghua bing li xue za zhi = Chinese journal of pathology